Impax Laboratories (IPXL)

18.44 +0.02  +0.11%  May 20, 4:59PM
Add to Watchlists Create an Alert

Impax Laboratories Price / Sales Ratio TTM:

2.095 for May 20, 2013
View Full Chart

Impax Laboratories Price / Sales Ratio TTM Chart

    Impax Laboratories Historical Price / Sales Ratio TTM Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 63   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    May 20, 2013 2.095
    May 17, 2013 2.093
    May 16, 2013 2.118
    May 15, 2013 2.044
    May 14, 2013 2.050
    May 13, 2013 2.021
    May 10, 2013 1.977
    May 9, 2013 1.835
    May 8, 2013 1.859
    May 7, 2013 1.858
    May 6, 2013 1.925
    May 3, 2013 1.932
    May 2, 2013 1.914
    May 1, 2013 1.974
    April 30, 2013 1.988
    April 29, 2013 1.993
    April 26, 2013 2.002
    April 25, 2013 1.986
    April 24, 2013 1.985
    April 23, 2013 2.003
    April 22, 2013 1.937
    April 19, 2013 1.901
    April 18, 2013 1.836
    April 17, 2013 1.835
    April 16, 2013 1.844
       
    April 15, 2013 1.828
    April 12, 2013 1.870
    April 11, 2013 1.875
    April 10, 2013 1.878
    April 9, 2013 1.819
    April 8, 2013 1.825
    April 5, 2013 1.849
    April 4, 2013 1.821
    April 3, 2013 1.807
    April 2, 2013 1.737
    April 1, 2013 1.737
    March 28, 2013 1.813
    March 27, 2013 1.810
    March 26, 2013 1.830
    March 25, 2013 1.815
    March 22, 2013 1.834
    March 21, 2013 1.826
    March 20, 2013 1.864
    March 19, 2013 1.828
    March 18, 2013 1.834
    March 15, 2013 1.851
    March 14, 2013 1.908
    March 13, 2013 1.922
    March 12, 2013 1.965
    March 11, 2013 1.983

    About Price to Sales Ratio

    The price to sales ratio (PS ratio) is calculated by dividing stock price by the revenue per share. It is most useful for comparing companies within a sector or industry because "normal" values for this ratio vary from industry to industry. In general, low price to sales ratios are more appealing because they suggest that a company is undervalued.

    An example illustrating why PS ratios should not be compared across industries: On June 21, 2010, Starbucks had a PS ratio of 1.12 while Yahoo! had a PS ratio of 2.56. In other words, Yahoo! shareholders were paying $2.56 for $1 of sales while Starbucks shareholders would only pay $1.12 for $1 of sales. However, at that same moment, the two companies' price to earnings ratios were virtually identical (Starbucks: 28.09 and Yahoo!: 27.78). Hence, shareholders were paying nearly the same amount for $1.00 in earnings. The PS ratios, though, are less comparable since Yahoo!'s profit margins are much higher than that of Starbucks.
    Learn More

    Get data for

    IPXL Price / Sales Ratio TTM Benchmarks

    Companies
    Endo Health Solutions 1.317
    Actavis 2.570
    Teva Pharmaceutical Industries 1.733

    IPXL Price / Sales Ratio TTM Rankings

    Overall 66th percentile
    2690 of 8002
    Sector 70th percentile
    191 of 650 in Healthcare
    Industry 78th percentile
    14 of 65 in Drug Manufacturers - Specialty & Generic

    IPXL Price / Sales Ratio TTM Range, Past 5 Years

    Minimum 0.7187 Jan 14 2009
    Maximum 3.708 Dec 30 2009
    Average 2.235